Suven Life Sciences

Suven Life Sciences is a biopharmaceutical company dedicated to discovering and developing novel pharmaceutical products for a wide range of Central Nervous System (CNS) disorders. The company's vision is to achieve a breakthrough innovation by singularly focusing on New Chemical Entities for CNS conditions, a commitment it has held for 20 years. It is uniquely positioned as the only Indian NCE-focused player with such a large basket of molecules specifically targeting disorders of the brain and spinal cord. Its core mission involves developing solutions for diseases with significant unmet medical needs, such as Alzheimer's, dementia, and narcolepsy, through its specialized research programs and clinical trials. Strategically, the company focuses on targets with novel and differentiated mechanisms of action, targeting indications that have high unmet needs and attractive commercial opportunities to ensure efficient development. This focused pursuit has resulted in a portfolio of 13 new chemical entities, which includes 7 assets in clinical stages and 6 projects in the research pipeline.;